Danielle-Roberts(updated) - Headshot

Danielle Roberts,

MS, MMSc, PA-C

Danielle Roberts,

MS, MMSc, PA-C

Associate Chief of Education, Winship Cancer Institute of Emory University

Danielle-Roberts(updated) - Headshot

Danielle Roberts,

MS, MMSc, PA-C

Associate Chief of Education, Winship Cancer Institute of Emory University

Danielle Roberts serves as the director for the APP Fellowship Program. She graduated from Emory University’s Physician Assistant Program in 2007. Upon graduation, Danielle worked in community oncology before joining the Winship Cancer Institute in 2011.  She has enjoyed working in many oncologic specialties including community oncology, survivorship, GVHD, and in her current position in malignant hematology. Danielle currently serves as the Associate Chief of Education for the Winship Cancer Institute and is Society Leader and adjunct faculty for the Emory University Physician Assistant Program.  She recently graduated from the WHEA Teaching Fellowship and was honored with the 2022 Physician Assistant of the Year by the Emory Physician Assistant program.

Provided by an unrestricted grant from

Danielle-Roberts - Headshot

Danielle's Shared Resources

Study Highlights High Early Mortality in Multiple Myeloma, Especially Among Older, Male, and Minority Patients

Early mortality (EM) is a concern in hematologic malignancies, including multiple myeloma (MM), where mortality rates remain high within the first two years of diagnosis. Despite advances in treatment over...
CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

Tailoring CAR-T Therapy for Older Adults: Addressing Frailty and Improving Outcomes

CAR-T therapy has been effective in treating relapsed/refractory hematologic cancers like multiple myeloma and diffuse large B-cell lymphoma, especially in older adults. However, its use in patients aged 75 and...
CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

NSD2 Overexpression in t(4;14) Multiple Myeloma Identifies AK2 as a New Therapeutic Target

In a recently published study, researchers revealed that NSD2 overexpression in t(4;14) multiple myeloma (MM) redirects S-adenosylmethionine (SAM) toward excessive methylation of the epigenome, specifically histone H3K36 dimethylation....
CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

Provided by an unrestricted grant from

Share